Showing results (101-110 of 157) with videos related to
Sort By:
Pageof 16
Urologic Oncology|December 14, 2020
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancerHirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, et al.Journal of the American Heart Association|July 2, 2018
Continuous ST-Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery DiseaseTetsuya Watanabe, Keiji Hirooka, Yoshio Furukawa, et al.Prostate International|March 25, 2024
Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective studyNaoki Fujita, Shingo Hatakeyama, Ryuji Tabata, et al.Cancer Medicine|January 17, 2021
N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomasHirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|June 6, 2020
Geriatric 8 screening of frailty in patients with prostate cancerMasaki Momota, Shingo Hatakeyama, Osamu Soma, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|May 24, 2021
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective studyTakuma Narita, Shingo Hatakeyama, Kazuyuki Numakura, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|March 10, 2020
STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasisKazutaka Okita, Shingo Hatakeyama, Atsushi Imai, et al.Plos One|November 1, 2014
The plasma B-type natriuretic peptide levels are low in males with stable ischemic heart disease (IHD) compared to those observed in patients with non-IHD: a retrospective studyKosuke Minai, Takayuki Ogawa, Makoto Kawai, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|August 23, 2024
Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapyHikari Miura, Shingo Hatakeyama, Ryuji Tabata, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|July 5, 2023
Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective studyRyuma Tanaka, Shingo Hatakeyama, Shintaro Narita, et al.Pageof 16